US 11045472
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
granted A61KA61K31/4709A61K31/517
Quick answer
US patent 11045472 (Quinazoline-pyridine derivatives for the treatment of cancer-related disorders) held by Arcus Biosciences, Inc. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4709, A61K31/517, A61K31/704, A61K33/243